Differentiated Thyroid Carcinoma
Conditions
Interventions
Control group:Euthyrox was administered orally, and the dose was determined according to the inhibition standard of DTC diagnosis and treatment guidelines.
treatment group:On the basis of Euthyrox treatment, the Thyroid Carcinoma postoperative prescription was added orally, 1 dose daily. Drug composition: Codonopsis, ophiopogon, Schisandrae, Prunella vul
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
25 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Patients aged from 25 to 70 years old were diagnosed as DTC by postoperative pathology; 2) patients with thyroid cancer after surgery (or after postoperative iodine-131 therapy) routinely treated with Euthyrox, TSH suppression value reached the guideline standard; 3) qi and Yin deficiency combined with liver depression in TCM syndrome differentiation; 4) patients who signed informed consent.
Exclusion criteria
Exclusion criteria: 1) patients with serious systemic diseases such as heart, liver, kidney and mental diseases; 2) Allergic to the ingredients contained in the drug; 3) the presence of distant metastasis; 4) pregnant and lactating women; 5) those who were participating in other clinical drug trials 6) patients who did not sign the informed consent; Those fulfilling any of the above criteria were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30; | — |
Secondary
| Measure | Time frame |
|---|---|
| Thyroglobulin;TCM Syndrome Score;Thyroid ultrasound;Thyroid function;Grade of therapeutic response; | — |
Countries
China
Contacts
Public ContactXia Zhongyuan
China-Japan Friendship Hospital
Outcome results
None listed